Vaccination coverage and breakthrough infections of COVID-19 during the second wave among staff of selected medical institutions in India.
India experienced the second wave of SARS-CoV-2 infection from April 3 to June 10, 2021. During the second wave, Delta variant B.1617.2 emerged as the predominant strain, spiking cases from 12.5 million to 29.3 million (cumulative) by the end of the surge in India. Vaccines against COVID-19 are a po...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Manju Rahi [verfasserIn] Chander Prakash Yadav [verfasserIn] Sundus Shafat Ahmad [verfasserIn] Nitika [verfasserIn] Payal Das [verfasserIn] Shweta Sharma [verfasserIn] Rajendra Kumar Baharia [verfasserIn] Debdutta Bhattacharya [verfasserIn] Pradeep Deshmukh [verfasserIn] Amey Dhatrak [verfasserIn] Sandeep Dogra [verfasserIn] Alex Eapen [verfasserIn] Pawan Goel [verfasserIn] Nafis Faizi [verfasserIn] Siraj A Khan [verfasserIn] Sanjay Kumar Kochar [verfasserIn] Aditya Kochar [verfasserIn] Ashwani Kumar [verfasserIn] Anuj Mundra [verfasserIn] Rahul Narang [verfasserIn] Kanwar Narain [verfasserIn] Krishna Pandey [verfasserIn] Sanghamitra Pati [verfasserIn] Pankaja Raghav [verfasserIn] Ritesh Ranjha [verfasserIn] Salman Shah [verfasserIn] Kuldeep Singh [verfasserIn] Piyoosh Kumar Singh [verfasserIn] Raj Kumar Singh [verfasserIn] Vijesh Shreedhar Kuttiatt [verfasserIn] Ravinder Soni [verfasserIn] Uragayala Sreehari [verfasserIn] Sumit Malhotra [verfasserIn] Amit Sharma [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2023 |
|---|
| Übergeordnetes Werk: |
In: PLOS Global Public Health - Public Library of Science (PLoS), 2022, 3(2023), 4, p e0000946 |
|---|---|
| Übergeordnetes Werk: |
volume:3 ; year:2023 ; number:4, p e0000946 |
| Links: |
|---|
| DOI / URN: |
10.1371/journal.pgph.0000946 |
|---|
| Katalog-ID: |
DOAJ08898155X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ08898155X | ||
| 003 | DE-627 | ||
| 005 | 20230505005440.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230505s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1371/journal.pgph.0000946 |2 doi | |
| 035 | |a (DE-627)DOAJ08898155X | ||
| 035 | |a (DE-599)DOAJf400a964d9cd4a1a90a147f4c13f981e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RA1-1270 | |
| 100 | 0 | |a Manju Rahi |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Vaccination coverage and breakthrough infections of COVID-19 during the second wave among staff of selected medical institutions in India. |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a India experienced the second wave of SARS-CoV-2 infection from April 3 to June 10, 2021. During the second wave, Delta variant B.1617.2 emerged as the predominant strain, spiking cases from 12.5 million to 29.3 million (cumulative) by the end of the surge in India. Vaccines against COVID-19 are a potent tool to control and end the pandemic in addition to other control measures. India rolled out its vaccination programme on January 16, 2021, initially with two vaccines that were given emergency authorization-Covaxin (BBV152) and Covishield (ChAdOx1 nCoV- 19). Vaccination was initially started for the elderly (60+) and front-line workers and then gradually opened to different age groups. The second wave hit when vaccination was picking up pace in India. There were instances of vaccinated people (fully and partially) getting infected, and reinfections were also reported. We undertook a survey of staff (front line health care workers and supporting) of 15 medical colleges and research institutes across India to assess the vaccination coverage, incidence of breakthrough infections, and reinfections among them from June 2 to July 10, 2021. A total of 1876 staff participated, and 1484 forms were selected for analysis after removing duplicates and erroneous entries (n = 392). We found that among the respondents at the time of response, 17.6% were unvaccinated, 19.8% were partially vaccinated (received the first dose), and 62.5% were fully vaccinated (received both doses). Incidence of breakthrough infections was 8.7% among the 801 individuals (70/801) tested at least 14 days after the 2nd dose of vaccine. Eight participants reported reinfection in the overall infected group and reinfection incidence rate was 5.1%. Out of (N = 349) infected individuals 243 (69.6%) were unvaccinated and 106 (30.3%) were vaccinated. Our findings reveal the protective effect of vaccination and its role as an essential tool in the struggle against this pandemic. | ||
| 653 | 0 | |a Public aspects of medicine | |
| 700 | 0 | |a Chander Prakash Yadav |e verfasserin |4 aut | |
| 700 | 0 | |a Sundus Shafat Ahmad |e verfasserin |4 aut | |
| 700 | 0 | |a Nitika |e verfasserin |4 aut | |
| 700 | 0 | |a Payal Das |e verfasserin |4 aut | |
| 700 | 0 | |a Shweta Sharma |e verfasserin |4 aut | |
| 700 | 0 | |a Rajendra Kumar Baharia |e verfasserin |4 aut | |
| 700 | 0 | |a Debdutta Bhattacharya |e verfasserin |4 aut | |
| 700 | 0 | |a Pradeep Deshmukh |e verfasserin |4 aut | |
| 700 | 0 | |a Amey Dhatrak |e verfasserin |4 aut | |
| 700 | 0 | |a Sandeep Dogra |e verfasserin |4 aut | |
| 700 | 0 | |a Alex Eapen |e verfasserin |4 aut | |
| 700 | 0 | |a Pawan Goel |e verfasserin |4 aut | |
| 700 | 0 | |a Nafis Faizi |e verfasserin |4 aut | |
| 700 | 0 | |a Siraj A Khan |e verfasserin |4 aut | |
| 700 | 0 | |a Sanjay Kumar Kochar |e verfasserin |4 aut | |
| 700 | 0 | |a Aditya Kochar |e verfasserin |4 aut | |
| 700 | 0 | |a Ashwani Kumar |e verfasserin |4 aut | |
| 700 | 0 | |a Anuj Mundra |e verfasserin |4 aut | |
| 700 | 0 | |a Rahul Narang |e verfasserin |4 aut | |
| 700 | 0 | |a Kanwar Narain |e verfasserin |4 aut | |
| 700 | 0 | |a Krishna Pandey |e verfasserin |4 aut | |
| 700 | 0 | |a Sanghamitra Pati |e verfasserin |4 aut | |
| 700 | 0 | |a Pankaja Raghav |e verfasserin |4 aut | |
| 700 | 0 | |a Ritesh Ranjha |e verfasserin |4 aut | |
| 700 | 0 | |a Salman Shah |e verfasserin |4 aut | |
| 700 | 0 | |a Kuldeep Singh |e verfasserin |4 aut | |
| 700 | 0 | |a Piyoosh Kumar Singh |e verfasserin |4 aut | |
| 700 | 0 | |a Raj Kumar Singh |e verfasserin |4 aut | |
| 700 | 0 | |a Vijesh Shreedhar Kuttiatt |e verfasserin |4 aut | |
| 700 | 0 | |a Ravinder Soni |e verfasserin |4 aut | |
| 700 | 0 | |a Uragayala Sreehari |e verfasserin |4 aut | |
| 700 | 0 | |a Sumit Malhotra |e verfasserin |4 aut | |
| 700 | 0 | |a Amit Sharma |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t PLOS Global Public Health |d Public Library of Science (PLoS), 2022 |g 3(2023), 4, p e0000946 |w (DE-627)177799649X |w (DE-600)3101394-6 |x 27673375 |7 nnns |
| 773 | 1 | 8 | |g volume:3 |g year:2023 |g number:4, p e0000946 |
| 856 | 4 | 0 | |u https://doi.org/10.1371/journal.pgph.0000946 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/f400a964d9cd4a1a90a147f4c13f981e |z kostenfrei |
| 856 | 4 | 0 | |u https://doi.org/10.1371/journal.pgph.0000946 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2767-3375 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a GBV_ILN_23 | ||
| 912 | |a GBV_ILN_24 | ||
| 912 | |a GBV_ILN_31 | ||
| 912 | |a GBV_ILN_39 | ||
| 912 | |a GBV_ILN_40 | ||
| 912 | |a GBV_ILN_60 | ||
| 912 | |a GBV_ILN_62 | ||
| 912 | |a GBV_ILN_63 | ||
| 912 | |a GBV_ILN_65 | ||
| 912 | |a GBV_ILN_69 | ||
| 912 | |a GBV_ILN_73 | ||
| 912 | |a GBV_ILN_74 | ||
| 912 | |a GBV_ILN_95 | ||
| 912 | |a GBV_ILN_105 | ||
| 912 | |a GBV_ILN_110 | ||
| 912 | |a GBV_ILN_151 | ||
| 912 | |a GBV_ILN_161 | ||
| 912 | |a GBV_ILN_170 | ||
| 912 | |a GBV_ILN_206 | ||
| 912 | |a GBV_ILN_213 | ||
| 912 | |a GBV_ILN_230 | ||
| 912 | |a GBV_ILN_285 | ||
| 912 | |a GBV_ILN_293 | ||
| 912 | |a GBV_ILN_602 | ||
| 912 | |a GBV_ILN_2001 | ||
| 912 | |a GBV_ILN_2003 | ||
| 912 | |a GBV_ILN_2005 | ||
| 912 | |a GBV_ILN_2009 | ||
| 912 | |a GBV_ILN_2014 | ||
| 912 | |a GBV_ILN_2522 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4037 | ||
| 912 | |a GBV_ILN_4112 | ||
| 912 | |a GBV_ILN_4125 | ||
| 912 | |a GBV_ILN_4126 | ||
| 912 | |a GBV_ILN_4249 | ||
| 912 | |a GBV_ILN_4305 | ||
| 912 | |a GBV_ILN_4306 | ||
| 912 | |a GBV_ILN_4307 | ||
| 912 | |a GBV_ILN_4313 | ||
| 912 | |a GBV_ILN_4322 | ||
| 912 | |a GBV_ILN_4323 | ||
| 912 | |a GBV_ILN_4324 | ||
| 912 | |a GBV_ILN_4325 | ||
| 912 | |a GBV_ILN_4338 | ||
| 912 | |a GBV_ILN_4367 | ||
| 912 | |a GBV_ILN_4700 | ||
| 951 | |a AR | ||
| 952 | |d 3 |j 2023 |e 4, p e0000946 | ||
| author_variant |
m r mr c p y cpy s s a ssa n p d pd s s ss r k b rkb d b db p d pd a d ad s d sd a e ae p g pg n f nf s a k sak s k k skk a k ak a k ak a m am r n rn k n kn k p kp s p sp p r pr r r rr s s ss k s ks p k s pks r k s rks v s k vsk r s rs u s us s m sm a s as |
|---|---|
| matchkey_str |
article:27673375:2023----::acntocvrgadratruhnetosfoi1drnteeodaemnsaffe |
| hierarchy_sort_str |
2023 |
| callnumber-subject-code |
RA |
| publishDate |
2023 |
| allfields |
10.1371/journal.pgph.0000946 doi (DE-627)DOAJ08898155X (DE-599)DOAJf400a964d9cd4a1a90a147f4c13f981e DE-627 ger DE-627 rakwb eng RA1-1270 Manju Rahi verfasserin aut Vaccination coverage and breakthrough infections of COVID-19 during the second wave among staff of selected medical institutions in India. 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier India experienced the second wave of SARS-CoV-2 infection from April 3 to June 10, 2021. During the second wave, Delta variant B.1617.2 emerged as the predominant strain, spiking cases from 12.5 million to 29.3 million (cumulative) by the end of the surge in India. Vaccines against COVID-19 are a potent tool to control and end the pandemic in addition to other control measures. India rolled out its vaccination programme on January 16, 2021, initially with two vaccines that were given emergency authorization-Covaxin (BBV152) and Covishield (ChAdOx1 nCoV- 19). Vaccination was initially started for the elderly (60+) and front-line workers and then gradually opened to different age groups. The second wave hit when vaccination was picking up pace in India. There were instances of vaccinated people (fully and partially) getting infected, and reinfections were also reported. We undertook a survey of staff (front line health care workers and supporting) of 15 medical colleges and research institutes across India to assess the vaccination coverage, incidence of breakthrough infections, and reinfections among them from June 2 to July 10, 2021. A total of 1876 staff participated, and 1484 forms were selected for analysis after removing duplicates and erroneous entries (n = 392). We found that among the respondents at the time of response, 17.6% were unvaccinated, 19.8% were partially vaccinated (received the first dose), and 62.5% were fully vaccinated (received both doses). Incidence of breakthrough infections was 8.7% among the 801 individuals (70/801) tested at least 14 days after the 2nd dose of vaccine. Eight participants reported reinfection in the overall infected group and reinfection incidence rate was 5.1%. Out of (N = 349) infected individuals 243 (69.6%) were unvaccinated and 106 (30.3%) were vaccinated. Our findings reveal the protective effect of vaccination and its role as an essential tool in the struggle against this pandemic. Public aspects of medicine Chander Prakash Yadav verfasserin aut Sundus Shafat Ahmad verfasserin aut Nitika verfasserin aut Payal Das verfasserin aut Shweta Sharma verfasserin aut Rajendra Kumar Baharia verfasserin aut Debdutta Bhattacharya verfasserin aut Pradeep Deshmukh verfasserin aut Amey Dhatrak verfasserin aut Sandeep Dogra verfasserin aut Alex Eapen verfasserin aut Pawan Goel verfasserin aut Nafis Faizi verfasserin aut Siraj A Khan verfasserin aut Sanjay Kumar Kochar verfasserin aut Aditya Kochar verfasserin aut Ashwani Kumar verfasserin aut Anuj Mundra verfasserin aut Rahul Narang verfasserin aut Kanwar Narain verfasserin aut Krishna Pandey verfasserin aut Sanghamitra Pati verfasserin aut Pankaja Raghav verfasserin aut Ritesh Ranjha verfasserin aut Salman Shah verfasserin aut Kuldeep Singh verfasserin aut Piyoosh Kumar Singh verfasserin aut Raj Kumar Singh verfasserin aut Vijesh Shreedhar Kuttiatt verfasserin aut Ravinder Soni verfasserin aut Uragayala Sreehari verfasserin aut Sumit Malhotra verfasserin aut Amit Sharma verfasserin aut In PLOS Global Public Health Public Library of Science (PLoS), 2022 3(2023), 4, p e0000946 (DE-627)177799649X (DE-600)3101394-6 27673375 nnns volume:3 year:2023 number:4, p e0000946 https://doi.org/10.1371/journal.pgph.0000946 kostenfrei https://doaj.org/article/f400a964d9cd4a1a90a147f4c13f981e kostenfrei https://doi.org/10.1371/journal.pgph.0000946 kostenfrei https://doaj.org/toc/2767-3375 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2014 GBV_ILN_2522 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 3 2023 4, p e0000946 |
| spelling |
10.1371/journal.pgph.0000946 doi (DE-627)DOAJ08898155X (DE-599)DOAJf400a964d9cd4a1a90a147f4c13f981e DE-627 ger DE-627 rakwb eng RA1-1270 Manju Rahi verfasserin aut Vaccination coverage and breakthrough infections of COVID-19 during the second wave among staff of selected medical institutions in India. 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier India experienced the second wave of SARS-CoV-2 infection from April 3 to June 10, 2021. During the second wave, Delta variant B.1617.2 emerged as the predominant strain, spiking cases from 12.5 million to 29.3 million (cumulative) by the end of the surge in India. Vaccines against COVID-19 are a potent tool to control and end the pandemic in addition to other control measures. India rolled out its vaccination programme on January 16, 2021, initially with two vaccines that were given emergency authorization-Covaxin (BBV152) and Covishield (ChAdOx1 nCoV- 19). Vaccination was initially started for the elderly (60+) and front-line workers and then gradually opened to different age groups. The second wave hit when vaccination was picking up pace in India. There were instances of vaccinated people (fully and partially) getting infected, and reinfections were also reported. We undertook a survey of staff (front line health care workers and supporting) of 15 medical colleges and research institutes across India to assess the vaccination coverage, incidence of breakthrough infections, and reinfections among them from June 2 to July 10, 2021. A total of 1876 staff participated, and 1484 forms were selected for analysis after removing duplicates and erroneous entries (n = 392). We found that among the respondents at the time of response, 17.6% were unvaccinated, 19.8% were partially vaccinated (received the first dose), and 62.5% were fully vaccinated (received both doses). Incidence of breakthrough infections was 8.7% among the 801 individuals (70/801) tested at least 14 days after the 2nd dose of vaccine. Eight participants reported reinfection in the overall infected group and reinfection incidence rate was 5.1%. Out of (N = 349) infected individuals 243 (69.6%) were unvaccinated and 106 (30.3%) were vaccinated. Our findings reveal the protective effect of vaccination and its role as an essential tool in the struggle against this pandemic. Public aspects of medicine Chander Prakash Yadav verfasserin aut Sundus Shafat Ahmad verfasserin aut Nitika verfasserin aut Payal Das verfasserin aut Shweta Sharma verfasserin aut Rajendra Kumar Baharia verfasserin aut Debdutta Bhattacharya verfasserin aut Pradeep Deshmukh verfasserin aut Amey Dhatrak verfasserin aut Sandeep Dogra verfasserin aut Alex Eapen verfasserin aut Pawan Goel verfasserin aut Nafis Faizi verfasserin aut Siraj A Khan verfasserin aut Sanjay Kumar Kochar verfasserin aut Aditya Kochar verfasserin aut Ashwani Kumar verfasserin aut Anuj Mundra verfasserin aut Rahul Narang verfasserin aut Kanwar Narain verfasserin aut Krishna Pandey verfasserin aut Sanghamitra Pati verfasserin aut Pankaja Raghav verfasserin aut Ritesh Ranjha verfasserin aut Salman Shah verfasserin aut Kuldeep Singh verfasserin aut Piyoosh Kumar Singh verfasserin aut Raj Kumar Singh verfasserin aut Vijesh Shreedhar Kuttiatt verfasserin aut Ravinder Soni verfasserin aut Uragayala Sreehari verfasserin aut Sumit Malhotra verfasserin aut Amit Sharma verfasserin aut In PLOS Global Public Health Public Library of Science (PLoS), 2022 3(2023), 4, p e0000946 (DE-627)177799649X (DE-600)3101394-6 27673375 nnns volume:3 year:2023 number:4, p e0000946 https://doi.org/10.1371/journal.pgph.0000946 kostenfrei https://doaj.org/article/f400a964d9cd4a1a90a147f4c13f981e kostenfrei https://doi.org/10.1371/journal.pgph.0000946 kostenfrei https://doaj.org/toc/2767-3375 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2014 GBV_ILN_2522 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 3 2023 4, p e0000946 |
| allfields_unstemmed |
10.1371/journal.pgph.0000946 doi (DE-627)DOAJ08898155X (DE-599)DOAJf400a964d9cd4a1a90a147f4c13f981e DE-627 ger DE-627 rakwb eng RA1-1270 Manju Rahi verfasserin aut Vaccination coverage and breakthrough infections of COVID-19 during the second wave among staff of selected medical institutions in India. 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier India experienced the second wave of SARS-CoV-2 infection from April 3 to June 10, 2021. During the second wave, Delta variant B.1617.2 emerged as the predominant strain, spiking cases from 12.5 million to 29.3 million (cumulative) by the end of the surge in India. Vaccines against COVID-19 are a potent tool to control and end the pandemic in addition to other control measures. India rolled out its vaccination programme on January 16, 2021, initially with two vaccines that were given emergency authorization-Covaxin (BBV152) and Covishield (ChAdOx1 nCoV- 19). Vaccination was initially started for the elderly (60+) and front-line workers and then gradually opened to different age groups. The second wave hit when vaccination was picking up pace in India. There were instances of vaccinated people (fully and partially) getting infected, and reinfections were also reported. We undertook a survey of staff (front line health care workers and supporting) of 15 medical colleges and research institutes across India to assess the vaccination coverage, incidence of breakthrough infections, and reinfections among them from June 2 to July 10, 2021. A total of 1876 staff participated, and 1484 forms were selected for analysis after removing duplicates and erroneous entries (n = 392). We found that among the respondents at the time of response, 17.6% were unvaccinated, 19.8% were partially vaccinated (received the first dose), and 62.5% were fully vaccinated (received both doses). Incidence of breakthrough infections was 8.7% among the 801 individuals (70/801) tested at least 14 days after the 2nd dose of vaccine. Eight participants reported reinfection in the overall infected group and reinfection incidence rate was 5.1%. Out of (N = 349) infected individuals 243 (69.6%) were unvaccinated and 106 (30.3%) were vaccinated. Our findings reveal the protective effect of vaccination and its role as an essential tool in the struggle against this pandemic. Public aspects of medicine Chander Prakash Yadav verfasserin aut Sundus Shafat Ahmad verfasserin aut Nitika verfasserin aut Payal Das verfasserin aut Shweta Sharma verfasserin aut Rajendra Kumar Baharia verfasserin aut Debdutta Bhattacharya verfasserin aut Pradeep Deshmukh verfasserin aut Amey Dhatrak verfasserin aut Sandeep Dogra verfasserin aut Alex Eapen verfasserin aut Pawan Goel verfasserin aut Nafis Faizi verfasserin aut Siraj A Khan verfasserin aut Sanjay Kumar Kochar verfasserin aut Aditya Kochar verfasserin aut Ashwani Kumar verfasserin aut Anuj Mundra verfasserin aut Rahul Narang verfasserin aut Kanwar Narain verfasserin aut Krishna Pandey verfasserin aut Sanghamitra Pati verfasserin aut Pankaja Raghav verfasserin aut Ritesh Ranjha verfasserin aut Salman Shah verfasserin aut Kuldeep Singh verfasserin aut Piyoosh Kumar Singh verfasserin aut Raj Kumar Singh verfasserin aut Vijesh Shreedhar Kuttiatt verfasserin aut Ravinder Soni verfasserin aut Uragayala Sreehari verfasserin aut Sumit Malhotra verfasserin aut Amit Sharma verfasserin aut In PLOS Global Public Health Public Library of Science (PLoS), 2022 3(2023), 4, p e0000946 (DE-627)177799649X (DE-600)3101394-6 27673375 nnns volume:3 year:2023 number:4, p e0000946 https://doi.org/10.1371/journal.pgph.0000946 kostenfrei https://doaj.org/article/f400a964d9cd4a1a90a147f4c13f981e kostenfrei https://doi.org/10.1371/journal.pgph.0000946 kostenfrei https://doaj.org/toc/2767-3375 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2014 GBV_ILN_2522 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 3 2023 4, p e0000946 |
| allfieldsGer |
10.1371/journal.pgph.0000946 doi (DE-627)DOAJ08898155X (DE-599)DOAJf400a964d9cd4a1a90a147f4c13f981e DE-627 ger DE-627 rakwb eng RA1-1270 Manju Rahi verfasserin aut Vaccination coverage and breakthrough infections of COVID-19 during the second wave among staff of selected medical institutions in India. 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier India experienced the second wave of SARS-CoV-2 infection from April 3 to June 10, 2021. During the second wave, Delta variant B.1617.2 emerged as the predominant strain, spiking cases from 12.5 million to 29.3 million (cumulative) by the end of the surge in India. Vaccines against COVID-19 are a potent tool to control and end the pandemic in addition to other control measures. India rolled out its vaccination programme on January 16, 2021, initially with two vaccines that were given emergency authorization-Covaxin (BBV152) and Covishield (ChAdOx1 nCoV- 19). Vaccination was initially started for the elderly (60+) and front-line workers and then gradually opened to different age groups. The second wave hit when vaccination was picking up pace in India. There were instances of vaccinated people (fully and partially) getting infected, and reinfections were also reported. We undertook a survey of staff (front line health care workers and supporting) of 15 medical colleges and research institutes across India to assess the vaccination coverage, incidence of breakthrough infections, and reinfections among them from June 2 to July 10, 2021. A total of 1876 staff participated, and 1484 forms were selected for analysis after removing duplicates and erroneous entries (n = 392). We found that among the respondents at the time of response, 17.6% were unvaccinated, 19.8% were partially vaccinated (received the first dose), and 62.5% were fully vaccinated (received both doses). Incidence of breakthrough infections was 8.7% among the 801 individuals (70/801) tested at least 14 days after the 2nd dose of vaccine. Eight participants reported reinfection in the overall infected group and reinfection incidence rate was 5.1%. Out of (N = 349) infected individuals 243 (69.6%) were unvaccinated and 106 (30.3%) were vaccinated. Our findings reveal the protective effect of vaccination and its role as an essential tool in the struggle against this pandemic. Public aspects of medicine Chander Prakash Yadav verfasserin aut Sundus Shafat Ahmad verfasserin aut Nitika verfasserin aut Payal Das verfasserin aut Shweta Sharma verfasserin aut Rajendra Kumar Baharia verfasserin aut Debdutta Bhattacharya verfasserin aut Pradeep Deshmukh verfasserin aut Amey Dhatrak verfasserin aut Sandeep Dogra verfasserin aut Alex Eapen verfasserin aut Pawan Goel verfasserin aut Nafis Faizi verfasserin aut Siraj A Khan verfasserin aut Sanjay Kumar Kochar verfasserin aut Aditya Kochar verfasserin aut Ashwani Kumar verfasserin aut Anuj Mundra verfasserin aut Rahul Narang verfasserin aut Kanwar Narain verfasserin aut Krishna Pandey verfasserin aut Sanghamitra Pati verfasserin aut Pankaja Raghav verfasserin aut Ritesh Ranjha verfasserin aut Salman Shah verfasserin aut Kuldeep Singh verfasserin aut Piyoosh Kumar Singh verfasserin aut Raj Kumar Singh verfasserin aut Vijesh Shreedhar Kuttiatt verfasserin aut Ravinder Soni verfasserin aut Uragayala Sreehari verfasserin aut Sumit Malhotra verfasserin aut Amit Sharma verfasserin aut In PLOS Global Public Health Public Library of Science (PLoS), 2022 3(2023), 4, p e0000946 (DE-627)177799649X (DE-600)3101394-6 27673375 nnns volume:3 year:2023 number:4, p e0000946 https://doi.org/10.1371/journal.pgph.0000946 kostenfrei https://doaj.org/article/f400a964d9cd4a1a90a147f4c13f981e kostenfrei https://doi.org/10.1371/journal.pgph.0000946 kostenfrei https://doaj.org/toc/2767-3375 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2014 GBV_ILN_2522 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 3 2023 4, p e0000946 |
| allfieldsSound |
10.1371/journal.pgph.0000946 doi (DE-627)DOAJ08898155X (DE-599)DOAJf400a964d9cd4a1a90a147f4c13f981e DE-627 ger DE-627 rakwb eng RA1-1270 Manju Rahi verfasserin aut Vaccination coverage and breakthrough infections of COVID-19 during the second wave among staff of selected medical institutions in India. 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier India experienced the second wave of SARS-CoV-2 infection from April 3 to June 10, 2021. During the second wave, Delta variant B.1617.2 emerged as the predominant strain, spiking cases from 12.5 million to 29.3 million (cumulative) by the end of the surge in India. Vaccines against COVID-19 are a potent tool to control and end the pandemic in addition to other control measures. India rolled out its vaccination programme on January 16, 2021, initially with two vaccines that were given emergency authorization-Covaxin (BBV152) and Covishield (ChAdOx1 nCoV- 19). Vaccination was initially started for the elderly (60+) and front-line workers and then gradually opened to different age groups. The second wave hit when vaccination was picking up pace in India. There were instances of vaccinated people (fully and partially) getting infected, and reinfections were also reported. We undertook a survey of staff (front line health care workers and supporting) of 15 medical colleges and research institutes across India to assess the vaccination coverage, incidence of breakthrough infections, and reinfections among them from June 2 to July 10, 2021. A total of 1876 staff participated, and 1484 forms were selected for analysis after removing duplicates and erroneous entries (n = 392). We found that among the respondents at the time of response, 17.6% were unvaccinated, 19.8% were partially vaccinated (received the first dose), and 62.5% were fully vaccinated (received both doses). Incidence of breakthrough infections was 8.7% among the 801 individuals (70/801) tested at least 14 days after the 2nd dose of vaccine. Eight participants reported reinfection in the overall infected group and reinfection incidence rate was 5.1%. Out of (N = 349) infected individuals 243 (69.6%) were unvaccinated and 106 (30.3%) were vaccinated. Our findings reveal the protective effect of vaccination and its role as an essential tool in the struggle against this pandemic. Public aspects of medicine Chander Prakash Yadav verfasserin aut Sundus Shafat Ahmad verfasserin aut Nitika verfasserin aut Payal Das verfasserin aut Shweta Sharma verfasserin aut Rajendra Kumar Baharia verfasserin aut Debdutta Bhattacharya verfasserin aut Pradeep Deshmukh verfasserin aut Amey Dhatrak verfasserin aut Sandeep Dogra verfasserin aut Alex Eapen verfasserin aut Pawan Goel verfasserin aut Nafis Faizi verfasserin aut Siraj A Khan verfasserin aut Sanjay Kumar Kochar verfasserin aut Aditya Kochar verfasserin aut Ashwani Kumar verfasserin aut Anuj Mundra verfasserin aut Rahul Narang verfasserin aut Kanwar Narain verfasserin aut Krishna Pandey verfasserin aut Sanghamitra Pati verfasserin aut Pankaja Raghav verfasserin aut Ritesh Ranjha verfasserin aut Salman Shah verfasserin aut Kuldeep Singh verfasserin aut Piyoosh Kumar Singh verfasserin aut Raj Kumar Singh verfasserin aut Vijesh Shreedhar Kuttiatt verfasserin aut Ravinder Soni verfasserin aut Uragayala Sreehari verfasserin aut Sumit Malhotra verfasserin aut Amit Sharma verfasserin aut In PLOS Global Public Health Public Library of Science (PLoS), 2022 3(2023), 4, p e0000946 (DE-627)177799649X (DE-600)3101394-6 27673375 nnns volume:3 year:2023 number:4, p e0000946 https://doi.org/10.1371/journal.pgph.0000946 kostenfrei https://doaj.org/article/f400a964d9cd4a1a90a147f4c13f981e kostenfrei https://doi.org/10.1371/journal.pgph.0000946 kostenfrei https://doaj.org/toc/2767-3375 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2014 GBV_ILN_2522 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 3 2023 4, p e0000946 |
| language |
English |
| source |
In PLOS Global Public Health 3(2023), 4, p e0000946 volume:3 year:2023 number:4, p e0000946 |
| sourceStr |
In PLOS Global Public Health 3(2023), 4, p e0000946 volume:3 year:2023 number:4, p e0000946 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Public aspects of medicine |
| isfreeaccess_bool |
true |
| container_title |
PLOS Global Public Health |
| authorswithroles_txt_mv |
Manju Rahi @@aut@@ Chander Prakash Yadav @@aut@@ Sundus Shafat Ahmad @@aut@@ Nitika @@aut@@ Payal Das @@aut@@ Shweta Sharma @@aut@@ Rajendra Kumar Baharia @@aut@@ Debdutta Bhattacharya @@aut@@ Pradeep Deshmukh @@aut@@ Amey Dhatrak @@aut@@ Sandeep Dogra @@aut@@ Alex Eapen @@aut@@ Pawan Goel @@aut@@ Nafis Faizi @@aut@@ Siraj A Khan @@aut@@ Sanjay Kumar Kochar @@aut@@ Aditya Kochar @@aut@@ Ashwani Kumar @@aut@@ Anuj Mundra @@aut@@ Rahul Narang @@aut@@ Kanwar Narain @@aut@@ Krishna Pandey @@aut@@ Sanghamitra Pati @@aut@@ Pankaja Raghav @@aut@@ Ritesh Ranjha @@aut@@ Salman Shah @@aut@@ Kuldeep Singh @@aut@@ Piyoosh Kumar Singh @@aut@@ Raj Kumar Singh @@aut@@ Vijesh Shreedhar Kuttiatt @@aut@@ Ravinder Soni @@aut@@ Uragayala Sreehari @@aut@@ Sumit Malhotra @@aut@@ Amit Sharma @@aut@@ |
| publishDateDaySort_date |
2023-01-01T00:00:00Z |
| hierarchy_top_id |
177799649X |
| id |
DOAJ08898155X |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">DOAJ08898155X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230505005440.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230505s2023 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1371/journal.pgph.0000946</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ08898155X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJf400a964d9cd4a1a90a147f4c13f981e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RA1-1270</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Manju Rahi</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Vaccination coverage and breakthrough infections of COVID-19 during the second wave among staff of selected medical institutions in India.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2023</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">India experienced the second wave of SARS-CoV-2 infection from April 3 to June 10, 2021. During the second wave, Delta variant B.1617.2 emerged as the predominant strain, spiking cases from 12.5 million to 29.3 million (cumulative) by the end of the surge in India. Vaccines against COVID-19 are a potent tool to control and end the pandemic in addition to other control measures. India rolled out its vaccination programme on January 16, 2021, initially with two vaccines that were given emergency authorization-Covaxin (BBV152) and Covishield (ChAdOx1 nCoV- 19). Vaccination was initially started for the elderly (60+) and front-line workers and then gradually opened to different age groups. The second wave hit when vaccination was picking up pace in India. There were instances of vaccinated people (fully and partially) getting infected, and reinfections were also reported. We undertook a survey of staff (front line health care workers and supporting) of 15 medical colleges and research institutes across India to assess the vaccination coverage, incidence of breakthrough infections, and reinfections among them from June 2 to July 10, 2021. A total of 1876 staff participated, and 1484 forms were selected for analysis after removing duplicates and erroneous entries (n = 392). We found that among the respondents at the time of response, 17.6% were unvaccinated, 19.8% were partially vaccinated (received the first dose), and 62.5% were fully vaccinated (received both doses). Incidence of breakthrough infections was 8.7% among the 801 individuals (70/801) tested at least 14 days after the 2nd dose of vaccine. Eight participants reported reinfection in the overall infected group and reinfection incidence rate was 5.1%. Out of (N = 349) infected individuals 243 (69.6%) were unvaccinated and 106 (30.3%) were vaccinated. Our findings reveal the protective effect of vaccination and its role as an essential tool in the struggle against this pandemic.</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Public aspects of medicine</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Chander Prakash Yadav</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Sundus Shafat Ahmad</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Nitika</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Payal Das</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Shweta Sharma</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Rajendra Kumar Baharia</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Debdutta Bhattacharya</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Pradeep Deshmukh</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Amey Dhatrak</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Sandeep Dogra</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Alex Eapen</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Pawan Goel</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Nafis Faizi</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Siraj A Khan</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Sanjay Kumar Kochar</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Aditya Kochar</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ashwani Kumar</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Anuj Mundra</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Rahul Narang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Kanwar Narain</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Krishna Pandey</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Sanghamitra Pati</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Pankaja Raghav</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ritesh Ranjha</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Salman Shah</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Kuldeep Singh</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Piyoosh Kumar Singh</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Raj Kumar Singh</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Vijesh Shreedhar Kuttiatt</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ravinder Soni</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Uragayala Sreehari</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Sumit Malhotra</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Amit Sharma</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">PLOS Global Public Health</subfield><subfield code="d">Public Library of Science (PLoS), 2022</subfield><subfield code="g">3(2023), 4, p e0000946</subfield><subfield code="w">(DE-627)177799649X</subfield><subfield code="w">(DE-600)3101394-6</subfield><subfield code="x">27673375</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:3</subfield><subfield code="g">year:2023</subfield><subfield code="g">number:4, p e0000946</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1371/journal.pgph.0000946</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/f400a964d9cd4a1a90a147f4c13f981e</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1371/journal.pgph.0000946</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2767-3375</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2001</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2522</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">3</subfield><subfield code="j">2023</subfield><subfield code="e">4, p e0000946</subfield></datafield></record></collection>
|
| callnumber-first |
R - Medicine |
| author |
Manju Rahi |
| spellingShingle |
Manju Rahi misc RA1-1270 misc Public aspects of medicine Vaccination coverage and breakthrough infections of COVID-19 during the second wave among staff of selected medical institutions in India. |
| authorStr |
Manju Rahi |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)177799649X |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut |
| collection |
DOAJ |
| remote_str |
true |
| callnumber-label |
RA1-1270 |
| illustrated |
Not Illustrated |
| issn |
27673375 |
| topic_title |
RA1-1270 Vaccination coverage and breakthrough infections of COVID-19 during the second wave among staff of selected medical institutions in India |
| topic |
misc RA1-1270 misc Public aspects of medicine |
| topic_unstemmed |
misc RA1-1270 misc Public aspects of medicine |
| topic_browse |
misc RA1-1270 misc Public aspects of medicine |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
PLOS Global Public Health |
| hierarchy_parent_id |
177799649X |
| hierarchy_top_title |
PLOS Global Public Health |
| isfreeaccess_txt |
true |
| familylinks_str_mv |
(DE-627)177799649X (DE-600)3101394-6 |
| title |
Vaccination coverage and breakthrough infections of COVID-19 during the second wave among staff of selected medical institutions in India. |
| ctrlnum |
(DE-627)DOAJ08898155X (DE-599)DOAJf400a964d9cd4a1a90a147f4c13f981e |
| title_full |
Vaccination coverage and breakthrough infections of COVID-19 during the second wave among staff of selected medical institutions in India |
| author_sort |
Manju Rahi |
| journal |
PLOS Global Public Health |
| journalStr |
PLOS Global Public Health |
| callnumber-first-code |
R |
| lang_code |
eng |
| isOA_bool |
true |
| recordtype |
marc |
| publishDateSort |
2023 |
| contenttype_str_mv |
txt |
| author_browse |
Manju Rahi Chander Prakash Yadav Sundus Shafat Ahmad Nitika Payal Das Shweta Sharma Rajendra Kumar Baharia Debdutta Bhattacharya Pradeep Deshmukh Amey Dhatrak Sandeep Dogra Alex Eapen Pawan Goel Nafis Faizi Siraj A Khan Sanjay Kumar Kochar Aditya Kochar Ashwani Kumar Anuj Mundra Rahul Narang Kanwar Narain Krishna Pandey Sanghamitra Pati Pankaja Raghav Ritesh Ranjha Salman Shah Kuldeep Singh Piyoosh Kumar Singh Raj Kumar Singh Vijesh Shreedhar Kuttiatt Ravinder Soni Uragayala Sreehari Sumit Malhotra Amit Sharma |
| container_volume |
3 |
| class |
RA1-1270 |
| format_se |
Elektronische Aufsätze |
| author-letter |
Manju Rahi |
| doi_str_mv |
10.1371/journal.pgph.0000946 |
| author2-role |
verfasserin |
| title_sort |
vaccination coverage and breakthrough infections of covid-19 during the second wave among staff of selected medical institutions in india |
| callnumber |
RA1-1270 |
| title_auth |
Vaccination coverage and breakthrough infections of COVID-19 during the second wave among staff of selected medical institutions in India. |
| abstract |
India experienced the second wave of SARS-CoV-2 infection from April 3 to June 10, 2021. During the second wave, Delta variant B.1617.2 emerged as the predominant strain, spiking cases from 12.5 million to 29.3 million (cumulative) by the end of the surge in India. Vaccines against COVID-19 are a potent tool to control and end the pandemic in addition to other control measures. India rolled out its vaccination programme on January 16, 2021, initially with two vaccines that were given emergency authorization-Covaxin (BBV152) and Covishield (ChAdOx1 nCoV- 19). Vaccination was initially started for the elderly (60+) and front-line workers and then gradually opened to different age groups. The second wave hit when vaccination was picking up pace in India. There were instances of vaccinated people (fully and partially) getting infected, and reinfections were also reported. We undertook a survey of staff (front line health care workers and supporting) of 15 medical colleges and research institutes across India to assess the vaccination coverage, incidence of breakthrough infections, and reinfections among them from June 2 to July 10, 2021. A total of 1876 staff participated, and 1484 forms were selected for analysis after removing duplicates and erroneous entries (n = 392). We found that among the respondents at the time of response, 17.6% were unvaccinated, 19.8% were partially vaccinated (received the first dose), and 62.5% were fully vaccinated (received both doses). Incidence of breakthrough infections was 8.7% among the 801 individuals (70/801) tested at least 14 days after the 2nd dose of vaccine. Eight participants reported reinfection in the overall infected group and reinfection incidence rate was 5.1%. Out of (N = 349) infected individuals 243 (69.6%) were unvaccinated and 106 (30.3%) were vaccinated. Our findings reveal the protective effect of vaccination and its role as an essential tool in the struggle against this pandemic. |
| abstractGer |
India experienced the second wave of SARS-CoV-2 infection from April 3 to June 10, 2021. During the second wave, Delta variant B.1617.2 emerged as the predominant strain, spiking cases from 12.5 million to 29.3 million (cumulative) by the end of the surge in India. Vaccines against COVID-19 are a potent tool to control and end the pandemic in addition to other control measures. India rolled out its vaccination programme on January 16, 2021, initially with two vaccines that were given emergency authorization-Covaxin (BBV152) and Covishield (ChAdOx1 nCoV- 19). Vaccination was initially started for the elderly (60+) and front-line workers and then gradually opened to different age groups. The second wave hit when vaccination was picking up pace in India. There were instances of vaccinated people (fully and partially) getting infected, and reinfections were also reported. We undertook a survey of staff (front line health care workers and supporting) of 15 medical colleges and research institutes across India to assess the vaccination coverage, incidence of breakthrough infections, and reinfections among them from June 2 to July 10, 2021. A total of 1876 staff participated, and 1484 forms were selected for analysis after removing duplicates and erroneous entries (n = 392). We found that among the respondents at the time of response, 17.6% were unvaccinated, 19.8% were partially vaccinated (received the first dose), and 62.5% were fully vaccinated (received both doses). Incidence of breakthrough infections was 8.7% among the 801 individuals (70/801) tested at least 14 days after the 2nd dose of vaccine. Eight participants reported reinfection in the overall infected group and reinfection incidence rate was 5.1%. Out of (N = 349) infected individuals 243 (69.6%) were unvaccinated and 106 (30.3%) were vaccinated. Our findings reveal the protective effect of vaccination and its role as an essential tool in the struggle against this pandemic. |
| abstract_unstemmed |
India experienced the second wave of SARS-CoV-2 infection from April 3 to June 10, 2021. During the second wave, Delta variant B.1617.2 emerged as the predominant strain, spiking cases from 12.5 million to 29.3 million (cumulative) by the end of the surge in India. Vaccines against COVID-19 are a potent tool to control and end the pandemic in addition to other control measures. India rolled out its vaccination programme on January 16, 2021, initially with two vaccines that were given emergency authorization-Covaxin (BBV152) and Covishield (ChAdOx1 nCoV- 19). Vaccination was initially started for the elderly (60+) and front-line workers and then gradually opened to different age groups. The second wave hit when vaccination was picking up pace in India. There were instances of vaccinated people (fully and partially) getting infected, and reinfections were also reported. We undertook a survey of staff (front line health care workers and supporting) of 15 medical colleges and research institutes across India to assess the vaccination coverage, incidence of breakthrough infections, and reinfections among them from June 2 to July 10, 2021. A total of 1876 staff participated, and 1484 forms were selected for analysis after removing duplicates and erroneous entries (n = 392). We found that among the respondents at the time of response, 17.6% were unvaccinated, 19.8% were partially vaccinated (received the first dose), and 62.5% were fully vaccinated (received both doses). Incidence of breakthrough infections was 8.7% among the 801 individuals (70/801) tested at least 14 days after the 2nd dose of vaccine. Eight participants reported reinfection in the overall infected group and reinfection incidence rate was 5.1%. Out of (N = 349) infected individuals 243 (69.6%) were unvaccinated and 106 (30.3%) were vaccinated. Our findings reveal the protective effect of vaccination and its role as an essential tool in the struggle against this pandemic. |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2014 GBV_ILN_2522 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 |
| container_issue |
4, p e0000946 |
| title_short |
Vaccination coverage and breakthrough infections of COVID-19 during the second wave among staff of selected medical institutions in India. |
| url |
https://doi.org/10.1371/journal.pgph.0000946 https://doaj.org/article/f400a964d9cd4a1a90a147f4c13f981e https://doaj.org/toc/2767-3375 |
| remote_bool |
true |
| author2 |
Chander Prakash Yadav Sundus Shafat Ahmad Nitika Payal Das Shweta Sharma Rajendra Kumar Baharia Debdutta Bhattacharya Pradeep Deshmukh Amey Dhatrak Sandeep Dogra Alex Eapen Pawan Goel Nafis Faizi Siraj A Khan Sanjay Kumar Kochar Aditya Kochar Ashwani Kumar Anuj Mundra Rahul Narang Kanwar Narain Krishna Pandey Sanghamitra Pati Pankaja Raghav Ritesh Ranjha Salman Shah Kuldeep Singh Piyoosh Kumar Singh Raj Kumar Singh Vijesh Shreedhar Kuttiatt Ravinder Soni Uragayala Sreehari Sumit Malhotra Amit Sharma |
| author2Str |
Chander Prakash Yadav Sundus Shafat Ahmad Nitika Payal Das Shweta Sharma Rajendra Kumar Baharia Debdutta Bhattacharya Pradeep Deshmukh Amey Dhatrak Sandeep Dogra Alex Eapen Pawan Goel Nafis Faizi Siraj A Khan Sanjay Kumar Kochar Aditya Kochar Ashwani Kumar Anuj Mundra Rahul Narang Kanwar Narain Krishna Pandey Sanghamitra Pati Pankaja Raghav Ritesh Ranjha Salman Shah Kuldeep Singh Piyoosh Kumar Singh Raj Kumar Singh Vijesh Shreedhar Kuttiatt Ravinder Soni Uragayala Sreehari Sumit Malhotra Amit Sharma |
| ppnlink |
177799649X |
| callnumber-subject |
RA - Public Medicine |
| mediatype_str_mv |
c |
| isOA_txt |
true |
| hochschulschrift_bool |
false |
| doi_str |
10.1371/journal.pgph.0000946 |
| callnumber-a |
RA1-1270 |
| up_date |
2024-07-03T20:33:49.111Z |
| _version_ |
1803591435277041664 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">DOAJ08898155X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230505005440.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230505s2023 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1371/journal.pgph.0000946</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ08898155X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJf400a964d9cd4a1a90a147f4c13f981e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RA1-1270</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Manju Rahi</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Vaccination coverage and breakthrough infections of COVID-19 during the second wave among staff of selected medical institutions in India.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2023</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">India experienced the second wave of SARS-CoV-2 infection from April 3 to June 10, 2021. During the second wave, Delta variant B.1617.2 emerged as the predominant strain, spiking cases from 12.5 million to 29.3 million (cumulative) by the end of the surge in India. Vaccines against COVID-19 are a potent tool to control and end the pandemic in addition to other control measures. India rolled out its vaccination programme on January 16, 2021, initially with two vaccines that were given emergency authorization-Covaxin (BBV152) and Covishield (ChAdOx1 nCoV- 19). Vaccination was initially started for the elderly (60+) and front-line workers and then gradually opened to different age groups. The second wave hit when vaccination was picking up pace in India. There were instances of vaccinated people (fully and partially) getting infected, and reinfections were also reported. We undertook a survey of staff (front line health care workers and supporting) of 15 medical colleges and research institutes across India to assess the vaccination coverage, incidence of breakthrough infections, and reinfections among them from June 2 to July 10, 2021. A total of 1876 staff participated, and 1484 forms were selected for analysis after removing duplicates and erroneous entries (n = 392). We found that among the respondents at the time of response, 17.6% were unvaccinated, 19.8% were partially vaccinated (received the first dose), and 62.5% were fully vaccinated (received both doses). Incidence of breakthrough infections was 8.7% among the 801 individuals (70/801) tested at least 14 days after the 2nd dose of vaccine. Eight participants reported reinfection in the overall infected group and reinfection incidence rate was 5.1%. Out of (N = 349) infected individuals 243 (69.6%) were unvaccinated and 106 (30.3%) were vaccinated. Our findings reveal the protective effect of vaccination and its role as an essential tool in the struggle against this pandemic.</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Public aspects of medicine</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Chander Prakash Yadav</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Sundus Shafat Ahmad</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Nitika</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Payal Das</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Shweta Sharma</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Rajendra Kumar Baharia</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Debdutta Bhattacharya</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Pradeep Deshmukh</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Amey Dhatrak</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Sandeep Dogra</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Alex Eapen</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Pawan Goel</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Nafis Faizi</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Siraj A Khan</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Sanjay Kumar Kochar</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Aditya Kochar</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ashwani Kumar</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Anuj Mundra</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Rahul Narang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Kanwar Narain</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Krishna Pandey</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Sanghamitra Pati</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Pankaja Raghav</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ritesh Ranjha</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Salman Shah</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Kuldeep Singh</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Piyoosh Kumar Singh</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Raj Kumar Singh</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Vijesh Shreedhar Kuttiatt</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ravinder Soni</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Uragayala Sreehari</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Sumit Malhotra</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Amit Sharma</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">PLOS Global Public Health</subfield><subfield code="d">Public Library of Science (PLoS), 2022</subfield><subfield code="g">3(2023), 4, p e0000946</subfield><subfield code="w">(DE-627)177799649X</subfield><subfield code="w">(DE-600)3101394-6</subfield><subfield code="x">27673375</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:3</subfield><subfield code="g">year:2023</subfield><subfield code="g">number:4, p e0000946</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1371/journal.pgph.0000946</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/f400a964d9cd4a1a90a147f4c13f981e</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1371/journal.pgph.0000946</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2767-3375</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2001</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2522</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">3</subfield><subfield code="j">2023</subfield><subfield code="e">4, p e0000946</subfield></datafield></record></collection>
|
| score |
7.4030848 |